Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
The feature you requested does not exist. However, we suggest the following feature:

Novozymes A/S : Transactions under Novozymes' stock buyback program

share with twitter share with LinkedIn share with facebook
07/06/2020 | 08:12am EDT

Please read the full announcement in the attached PDF

Attachment

  • 2020_42_Stock_Buybackprogram

© OMX, source OMX

share with twitter share with LinkedIn share with facebook
Latest news on NOVOZYMES A/S
07/06NOVOZYMES A/S : Transactions under Novozymes' stock buyback program
AQ
06/25NOVOZYMES A/S : acquires PrecisionBiotics Group to advance its business within h..
PU
06/22NOVOZYMES A/S : Transactions under Novozymes' stock buyback program
AQ
06/19NOVOZYMES A/S : in pro bono partnership to establish sustainable food supply in ..
PU
06/09NOVOZYMES A/S : Fewer cars mean more hand sanitizer
PU
06/08NOVOZYMES A/S : Transactions under Novozymes' stock buyback program
AQ
06/08NOVOZYMES A/S : ' financial calendar 2021
AQ
05/25NOVOZYMES A/S : Transactions under Novozymes' stock buyback program
AQ
05/25NOVOZYMES A/S : Trading by management and close relations of management
AQ
05/11NOVOZYMES A/S : Transactions under Novozymes' stock buyback program
AQ
More news
Financials
Sales 2020 14 403 M 2 183 M 2 183 M
Net income 2020 3 026 M 459 M 459 M
Net Debt 2020 3 892 M 590 M 590 M
P/E ratio 2020 36,2x
Yield 2020 1,39%
Capitalization 109 B 16 585 M 16 554 M
EV / Sales 2019
EV / Sales 2020 7,85x
Nbr of Employees 6 066
Free-Float 74,5%
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 18
Average target price 332,82 DKK
Last Close Price 389,70 DKK
Spread / Highest target 8,29%
Spread / Average Target -14,6%
Spread / Lowest Target -33,3%
EPS Revisions
Managers
NameTitle
Ester Baiget President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Thomas Videbaek COO, Executive VP-Research, Innovation & Supply
Lars Green Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang VP-Franklinton Biofuel, Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S19.54%16 585
ECOLAB INC.4.53%57 398
HENKEL AG & CO. KGAA-8.74%38 696
GIVAUDAN17.26%34 811
SIKA AG3.02%28 217
EMS-CHEMIE HOLDING AG17.12%18 528